% (95 % CI) persistent at end of time frame | ||||||||
---|---|---|---|---|---|---|---|---|
Site | Reference | Population, age (years) | Infection type | Time-frame (months) | Any HPV | HR | 16 | 18 |
Penile | Wikström; Sweden [21] | MSW, 18–54 | Prevalent/ Incident | 3.5 | 50 (23–77) | 57 (18–90) | 75 (19–99) | 0 (0–98) |
Grabowski; Uganda [24] | HIV- men, 15–49 HIV+ men, 15–49 | Prevalent Prevalent | 6 12 24 6 12 24 | 31 (27–37) 25 (20–30) 12 (9–16) 43 (37–48) 28 (23–34) 29 (25–34) | ||||
Anal | Nyitray; Brazil, Mexico, USA [35] | MSM, 18–70 MSW, 18–70 | Prevalent Prevalent | 6 6 | 59 (48–70) 32 (24–41) | 51 (36–66) 24 (14–37) | 73 (39–94) 0 (0–16) | 38 (9–76) 0 (0–84) |
Male Genital | Lajous; Mexico [27] | Male soldiers, 16–40 | Prevalent | 12 | 29.4 (21.6–38.2) | 31.0 (22.1–41.0) | 31.3 (11.0–58.7) | 0 (0–33.6) |
Oral | Pickard; USA [49] | Male/female students, 18–30 | Prevalent | 3 | 38 (19–59) | 42 (15–72) | 0 (0–98) | |
Kurose; Japan [52] | Male/female volunteers, 3–85 | Prevalent | 30 | 50 (9–93) | 0 (0–98) | 0 (0–98) | - |